Name | THR-β agonist 3 |
---|
Description | THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. |
---|---|
Related Catalog | |
References |
[1]. Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1. |
Molecular Formula | C29H32ClO5P |
---|---|
Molecular Weight | 526.99 |